French Jena D, Roark Christina L, Born Willi K, O'Brien Rebecca L
National Jewish Health, Integrated Department of Immunology, Denver, CO 80206, USA.
J Immunol. 2009 Feb 15;182(4):1892-900. doi: 10.4049/jimmunol.0803165.
Successful application of gammadelta T cells in adoptive cell therapies depends upon our ability to maintain these cells in vivo. Using an adoptive transfer model to study lymphopenia-induced homeostatic expansion, we show that CD8(+) and NK1.1(+) gammadelta T cell subsets are differentially regulated. While CD8(+) gammadelta T cells have an early and sustained advantage following transfer into TCRbeta(-/-)/delta(-/-) mice, NK1.1(+) gammadelta T cells proliferate slowly and are maintained at low numbers. The advantage of the CD8(+) subset could not be explained by increased bcl-2 or cytokine receptor expression but did correlate with Vgamma4(+) and Vdelta5(+) expression. Despite the role of CD8 in MHC class I recognition by alphabeta T cells, beta(2)-microglobulin (beta(2)m)-associated MHC class I molecules were not required for CD8(+) gammadelta T cell homeostatic expansion. Surprisingly, all gammadelta T cells, including the CD8(+) subset, exhibited enhanced proliferation following adoptive transfer into Rag1(-/-)/beta(2)m(-/-) compared with Rag1(-/-) recipients. This effect was most notable for the NK1.1(+) subset, which expresses high levels of NKG2A/CD94 and Ly49. Although expression of these inhibitory receptors correlated with poor homeostatic expansion in the presence of beta(2)m, gammadelta T cell homeostatic proliferation in TCRbeta(-/-)/delta(-/-) mice was not altered in the presence of Ly49C/I- and NKG2-blocking Abs. While the mechanism by which beta(2)m negatively regulates gammadelta T cell homeostasis remains to be determined, this observation is unique to gammadelta T cells and confirms that multiple mechanisms are in place to maintain strict regulation of both the size and the composition of the gammadelta T cell pool.
γδT细胞在过继性细胞疗法中的成功应用取决于我们在体内维持这些细胞的能力。利用过继转移模型研究淋巴细胞减少诱导的稳态扩增,我们发现CD8(+)和NK1.1(+)γδT细胞亚群受到不同的调节。虽然CD8(+)γδT细胞在转入TCRβ(-/-)/δ(-/-)小鼠后具有早期和持续的优势,但NK1.1(+)γδT细胞增殖缓慢且数量维持在低水平。CD8(+)亚群的优势不能用bcl-2或细胞因子受体表达增加来解释,但确实与Vγ4(+)和Vδ5(+)表达相关。尽管CD8在αβT细胞识别MHC I类分子中起作用,但CD8(+)γδT细胞的稳态扩增并不需要β2-微球蛋白(β2m)相关的MHC I类分子。令人惊讶的是,与Rag1(-/-)受体相比,所有γδT细胞,包括CD8(+)亚群,在转入Rag1(-/-)/β2m(-/-)小鼠后过继转移后均表现出增殖增强。这种效应在NK1.1(+)亚群中最为显著,该亚群表达高水平的NKG2A/CD94和Ly49。尽管这些抑制性受体的表达与存在β2m时的稳态扩增不良相关,但在存在Ly49C/I-和NKG2阻断抗体的情况下,TCRβ(-/-)/δ(-/-)小鼠中γδT细胞的稳态增殖并未改变。虽然β2m负调节γδT细胞稳态的机制仍有待确定,但这一观察结果是γδT细胞特有的,并证实存在多种机制来维持对γδT细胞库大小和组成的严格调节。